This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of 4.35% and 1.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Medtronic (MDT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $101.99 in the latest trading session, marking a -0.72% move from the prior day.
Zimmer Biomet (ZBH) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Zimmer (ZBH) delivered earnings and revenue surprises of -0.51% and 0.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Medtronic (MDT) Reports First Procedure in Europe With Hugo RAS
by Zacks Equity Research
Medtronic's (MDT) Hugo RAS system was utilized to perform robotic prostatectomy at OLV Hospital in Aalst, Belgium.
Medtronic (MDT) Cardiovascular Line Rebounds, Spine Stays Soft
by Zacks Equity Research
Medtronic (MDT) is registering organic growth in the Cardiovascular, Neuroscience and Diabetes segments.
Medtronic (MDT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $103.49, moving +0.35% from the previous trading session.
Medtronic (MDT) Stock Moves -0.08%: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $104.09, moving -0.08% from the previous trading session.
DaVita's (DVA) Collaboration to Aid in Kidney Care Needs
by Zacks Equity Research
DaVita's (DVA) work with transplant providers and kidney doctors is likely to slow CKD progression and bolster access to home dialysis and kidney transplantation.
Medtronic (MDT) Undertakes Investment to Advance STEM Education
by Zacks Equity Research
The Medtronic Foundation, solely funded by Medtronic plc (MDT), entered into 13 new partnerships to bridge the inequity in STEM education among underrepresented and underserved communities.
Medtronic (MDT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $106.11, moving -1.53% from the previous trading session.
Medtronic's (MDT) DTM SCS Endurance Therapy Study Data Positive
by Zacks Equity Research
Medtronic's (MDT) DTM SCS endurance therapy offers meaningful clinical benefits by reducing pain, improving quality of life and offering meaningful device longevity for patients.
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $108.95 in the latest trading session, marking a +0.98% move from the prior day.
Medtronic (MDT) Gets MHLW Approval for Micra AV Sale in Japan
by Zacks Equity Research
The Micra AV approval is likely to boost Medtronic's (MDT) Cardiac Rhythm Management business while delivering the benefits of leadless pacing in Japan.
Medtronic (MDT) to Buy Affera, Expand in Electrophysiology
by Zacks Equity Research
Affera's full suite of solutions and technologies will complement Medtronic's (MDT) existing atrial and ventricular arrhythmia disease management portfolio.
The Zacks Analyst Blog Highlights: Meta Platforms, Inc., Bank of America Corporation, Mastercard Inc., Pfizer Inc. and Medtronic plc
by Zacks Equity Research
Meta Platforms, Inc., Bank of America Corporation and Mastercard Inc., Pfizer Inc. and Medtronic plc are highlighted in this analyst blog.
Medtronic (MDT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $106.39, moving +0.27% from the previous trading session.
Top Stock Reports for Meta Platforms, Bank of America & Mastercard
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (FB), Bank of America Corporation (BAC), and Mastercard Incorporated (MA).
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $103.95, moving -0.55% from the previous trading session.
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medtronic (MDT) to Gain From Expanded Medicare Coverage for CGM
by Zacks Equity Research
CMS' expanded Medicare coverage includes continuous glucose monitors that can be integrated with Medtronic's (MDT) insulin pumps.
4 Internet of Medical Things (IoMT) Stocks to Buy for 2022
by Riya Anand
Stocks like Boston Scientific (BSX), Medtronic (MDT), DexCom (DXCM) and Syneos Health (SYNH) are evolving rapidly in the field of IoMT.
Here's Why You Should Hold on to Medtronic (MDT) Stock for Now
by Zacks Equity Research
Investors are optimistic about Medtronic's (MDT) better-than-expected earnings in the fiscal second quarter and robust performance of the Diabetes arm.
Medtronic (MDT) Businesses Rebound Amid Raging Pandemic
by Zacks Equity Research
Medtronic (MDT) is registering strong organic growth in the Cardiovascular, Neuroscience and Diabetes segments on product launches.
Medtronic's (MDT) INVOS System Gets FDA 510 (k) Clearance
by Zacks Equity Research
Medtronic's (MDT) INVOS 7100 system can deliver key signals to pediatric clinicians for making time-sensitive decisions
Top Stock Reports for NVIDIA, Philip Morris & Sanofi
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Philip Morris International Inc. (PM) and Sanofi (SNY).